Assessment of Switching From Salmeterol/Fluticasone to Indacaterol/Glycopyrronium in a symtomaticCOPD Patient Cohort
Clinical trial NCT02516592 · COMPLETED
Trial details
- NCT number
- NCT02516592
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-13
- Primary completion
- 2017-05-04
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.